An exceptional metaplastic lobular breast carcinoma diagnosed through exome sequencing.


Journal

Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 12 09 2019
revised: 30 12 2019
accepted: 31 12 2019
pubmed: 26 1 2020
medline: 1 9 2020
entrez: 26 1 2020
Statut: ppublish

Résumé

Metaplastic breast carcinoma is a rare subtype of breast cancer. This subtype is mostly found in association with poorly differentiated ductal breast carcinomas and rarely with other breast carcinoma types. We report the case of a 69-year-old woman with an exceptional invasive lobular breast carcinoma associated with metaplastic squamous cell bone metastasis occurring 2 years after the initial breast cancer diagnosis. Whole-exome sequencing and subsequent immunohistochemistry of the lesions were used to link the squamous cell bone metastasis of unknown origin to the primary breast carcinoma initially diagnosed. Searching for primary carcinoma when metastatic lesions of unknown origin occur can be complex. Current molecular biology techniques may help pathologists in associating metastasis with the primary carcinoma by identifying shared specific gene mutations, even when different morphological and immunohistochemical profiles are observed between the tumours.

Identifiants

pubmed: 31980561
pii: jclinpath-2019-205783
doi: 10.1136/jclinpath-2019-205783
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

597-601

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Anthony Bergeron (A)

Department of Tumor Biology and Pathology, Pathology Unit, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France abergeron@cgfl.fr.

Isabelle Desmoulins (I)

Department of Clinical Oncology, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.

Francoise Beltjens (F)

Department of Tumor Biology and Pathology, Pathology Unit, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.

Sylvain Causeret (S)

Department of Surgery, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.

Celine Charon-Barra (C)

Department of Tumor Biology and Pathology, Pathology Unit, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.

Etienne Martin (E)

Department of Radiation Oncology, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.

Corentin Richard (C)

Department of Tumor Biology and Pathology, Molecular Biology Unit, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.

Romain Boidot (R)

Department of Tumor Biology and Pathology, Molecular Biology Unit, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.

Laurent Arnould (L)

Department of Tumor Biology and Pathology, Pathology Unit, Centre Georges-Francois Leclerc, Dijon, Bourgogne, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH